Literature DB >> 18184815

The A2b adenosine receptor protects against vascular injury.

Dan Yang1, Milka Koupenova, Donald J McCrann, Katherine J Kopeikina, Herbert M Kagan, Barbara M Schreiber, Katya Ravid.   

Abstract

The A2b adenosine receptor (A2bAR) is highly abundant in bone marrow macrophages and vascular smooth muscle cells (VSMC). To examine the functional significance of this receptor expression, we applied a femoral artery injury model to A2bAR knockout (KO) mice and showed that the A2bAR prevents vascular lesion formation in an injury model that resembles human restenosis after angioplasty. While considering related mechanisms, we noted higher levels of TNF-alpha, an up-regulator of CXCR4, and of VSMC proliferation in the injured KO mice. In accordance, CXCR4, which is known to attract progenitor cells during tissue regeneration, is up-regulated in lesions of the KO mice. In addition, aortic smooth muscle cells derived from A2bAR KO mice display greater proliferation in comparison with controls. Bone marrow transplantation experiments indicated that the majority of the signal for lesion formation in the null mice originates from bone marrow cells. Thus, this study highlights the significance of the A2bAR in regulating CXCR4 expression in vivo and in protecting against vascular lesion formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184815      PMCID: PMC2206615          DOI: 10.1073/pnas.0705563105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

2.  Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines.

Authors:  Sergey Ryzhov; Rinat Zaynagetdinov; Anna E Goldstein; Sergey V Novitskiy; Michael R Blackburn; Italo Biaggioni; Igor Feoktistov
Journal:  J Pharmacol Exp Ther       Date:  2007-10-26       Impact factor: 4.030

3.  Biological role of the CXCR4-SDF-1 axis in normal human hematopoietic cells.

Authors:  Marcin Majka; Mariusz Z Ratajczak
Journal:  Methods Mol Biol       Date:  2006

4.  Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation.

Authors:  Noel M Caplice; T Jared Bunch; Paul G Stalboerger; Shaohua Wang; David Simper; Dylan V Miller; Stephen J Russell; Mark R Litzow; William D Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-28       Impact factor: 11.205

5.  Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.

Authors:  Teruo Inoue; Masataka Sata; Yutaka Hikichi; Ryoichi Sohma; Daiju Fukuda; Toshihiko Uchida; Minoru Shimizu; Hiroshi Komoda; Koichi Node
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

6.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo.

Authors:  Kan Koizumi; Vassiliki Poulaki; Sven Doehmen; Gerhard Welsandt; Sven Radetzky; Alexandra Lappas; Norbert Kociok; Bernd Kirchhof; Antonia M Joussen
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

Review 8.  Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.

Authors:  Ayelet Dar; Orit Kollet; Tsvee Lapidot
Journal:  Exp Hematol       Date:  2006-08       Impact factor: 3.084

9.  Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury.

Authors:  Michael A Zimmerman; Craig H Selzman; Leonid L Reznikov; Stephanie A Miller; Christopher D Raeburn; Julie Emmick; Xianzhong Meng; Alden H Harken
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-08       Impact factor: 3.619

10.  Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.

Authors:  Aaron Z Fernandis; Rama P Cherla; Ramesh K Ganju
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

View more
  57 in total

1.  Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Authors:  Kengo Moriyama; Michail V Sitkovsky
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  A2b adenosine receptor regulates hyperlipidemia and atherosclerosis.

Authors:  Milka Koupenova; Hillary Johnston-Cox; Alexander Vezeridis; Haralambos Gavras; Dan Yang; Vassilis Zannis; Katya Ravid
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

3.  A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.

Authors:  Shannon H Carroll; Nathan A Wigner; Nitin Kulkarni; Hillary Johnston-Cox; Louis C Gerstenfeld; Katya Ravid
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

4.  The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.

Authors:  Harry Karmouty-Quintana; Hongyan Zhong; Luis Acero; Tingting Weng; Ernestina Melicoff; James D West; Anna Hemnes; Almut Grenz; Holger K Eltzschig; Timothy S Blackwell; Yang Xia; Richard A Johnston; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

5.  Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.

Authors:  Ulrich Schingnitz; Katherine Hartmann; Christopher F Macmanus; Tobias Eckle; Stephanie Zug; Sean P Colgan; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 6.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

7.  A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Peter Rosenberger; Holger K Eltzschig; Zoltán Spolarics; Pál Pacher; Zsolt Selmeczy; Balázs Koscsó; Leonóra Himer; E Sylvester Vizi; Michael R Blackburn; Edwin A Deitch; György Haskó
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 8.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 9.  A(2B) adenosine receptors in immunity and inflammation.

Authors:  György Haskó; Balázs Csóka; Zoltán H Németh; E Sylvester Vizi; Pál Pacher
Journal:  Trends Immunol       Date:  2009-05-07       Impact factor: 16.687

10.  Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury.

Authors:  Hongjie Chen; Dan Yang; Shannon H Carroll; Holger K Eltzschig; Katya Ravid
Journal:  Exp Hematol       Date:  2009-05       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.